Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Genital Neoplasms, Male × padeliporfin × Clear all

Phase

Status

Completed 3 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urogenital Neoplasms 1 Prostatic Neoplasms 1 Prostatic Diseases 1 Neoplasms by Site 1 Neoplasms 1 Male Urogenital Diseases 1 Genital Neoplasms, Male 1 Genital Diseases, Male 1 Carcinoma 1

Interventions

palladium-bacteriopheophorbide 1 padeliporfin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04225299 2020-11-13

Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer

Steba Biotech S.A.

Phase 3 Withdrawn

Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡